您当前的位置:首页 > 主题内容 > 临床麻醉 > 专家评述

体外循环心内直视手术围术期乌司他丁对血浆S100β蛋白及TNF表达的影响

时间:2010-08-24 09:08:51  来源:  作者:

[Abstract] Objective  To investigate the effect of ulinastatin on expression of S100βprotein and TNF-a  in patients undergoing open-heart surgery with cardiopulmonary bypass. Methods 30 adult patients undergoing elective open-heart surgery with cardiopulmonary bypass were randomly allocated to two groups (n15 each): ulinastation (U) and control (C) group. In group U, the patients received  ulinastain 10 000U/kg after induction of anesthesia and before CPB. Another ulinastain 10 000U/kg was added to the priming solution at the beginning of the CPB. In group C the patients received normal saline instead of ulinastain. Blood samples were taken from internal jugular vein 15min after initiation of CPB (T1), when discontinuation of CPB (T2), 2h (T3) and 24h (T4) after discontinuation of CPB for determination of plasma S100β protein and TNF-a levels. Results Plasma levels of S100β protein and TNF-a in group U were significantly lower than those in group C at T2 ( P0.01 and T3 ( P0.05. There were no difference between in both groups at T1 and T4 ( P0.05 ). The plasma level of S100β protein significantly increased at T2-4 as compared to the baseline value at T1 in both groups (P0.01. In group C, TNF-a  levels significantly increased at T2 and T3 as compared to the baseline value at T1P0.01);There was no significant change in the expression of TNF-a in group UP0.05)。Conclusions Ulinastatin can decrease the production of inflammatory cytokine TNF-a  and attenuate the expression of S100β protein in plasma, the biochemical sign of cerebral injury.

[Key words] Cardiopulmonary bypass; Trypsin inhibitors; S100 protein; Tumor necrosis factor

目前体外循环心脏直视手术后因神经系统缺陷引起的死亡率明显上升,而体外循环对中枢神经系统损伤是心脏手术所造成的非心血管致死性并发症的重要原因。研究表明,3%~6%体外循环心脏手术后的病人存在明显脑功能缺陷,通过神经精神检查发现脑损伤的发生率高达60%~70% [1-2]

乌司他丁是一种尿蛋白酶抑制剂,能有效、广谱抑制多种蛋白酶以及机体炎症因子的释放,保护机体重要脏器的功能。近年来,有报导乌司他丁对CPB期肾功能、肺功能、心肌缺血再灌注以及凝血功能均有一定的影响[3-4],而对CPB心内直视手术围术期脑损伤的影响如何尚有待研究。本研究通过观察CPB后不同时间点脑的血浆敏感标志物S100β蛋白、TNF-a的水平,探讨乌司他丁对CPB心内直视手术所致脑损伤的影响及其机制。

1资料与方法

1.1病例选择与分组 择期体外循环心内直视术病人30例,男11例,女19ASA级,年龄18~65岁,体重43~69kg随机分成两组:乌司他丁组(U组)和对照组(C组),每组15例。术前无心内膜炎、糖尿病、高血压、神经系统、免疫系统和精神疾病病史,肺肝肾功能未见异常;手术种类包括室间隔缺损(VSD)、房间隔缺损(ASD)根治术11例,二尖瓣置换术(MVR11例,主动脉瓣置换术(AVR8例。

1.2麻醉和处理  两组病人麻醉前30 min肌注吗啡5 mg、咪达唑仑3~5 mg及东莨菪碱0.3 mg。入室后连接DATEX-OHMEDA S/5监护仪监测心电图(ECG),脉搏血氧饱和度(SpO2, 局麻下桡动脉穿刺置管测平均动脉压(MAP,右颈内静脉置管测中心静脉压(CVP)。依次静脉注射咪达唑仑0.1 mg.kg-1, 芬太尼5~7 μg.kg-1及维库溴铵0.15mg.kg-1行麻醉诱导气管插管,术中连接NARKOMED GS麻醉机作控制呼吸,维持PETCO2 35~40 mmHg,术中以芬太尼5μg.kg-1.h-1、丙泊酚5mg.kg-1.h-1维库溴铵0.12mg.kg-1.h-1维持麻醉。肝素化后建立CPB使用德国Stockert SⅢ型体外循环机器和意大利Didecd鼓泡式人工肺。转流期间维持鼻咽温30~34MAP50~80 mmHg

U组麻醉诱导后、体外循环前将乌司他丁(批号:02050401, 广东天普生化医药股份有限公司)10 000 U/kg溶于50ml生理盐水中微量泵输入,CPB开始时再将乌司他丁10 000 U/kg加入体外循环机预充液中;C组用等容量的生理盐水。

1.3检测指标与处理  分别于CPB开始后15minT1)、CPB结束时(T2)、CPB结束后2hT3)、CPB结束后24hT4)时采颈内静脉血4ml,经-4低温4 000 r/min离心10 min,取血浆,用ELISA法测定血浆S100β蛋白浓度和TNFα的水平。(S100β和TNFα ELISA试剂盒均购自法国Besancon cedex公司)。

1.4统计学处理  采用SPSS13.0 for Windows统计软件进行统计分析,计量资料以均数±标准差(±s)表示,组间比较采用成组设计t检验,组内比较采用双因素方差分析;计数资料采用卡方检验。P0.05表示差异有统计学意义。

2 

2.1一般情况的比较 两组病人年龄、性别构成比、体重、手术种类构成比、CPB时间及主动脉阻断时间的差异均无统计学意义(P0.05(见表1)

2.2两组S100β蛋白浓度的比较 US100βT2时点明显低于C P0.01);T3时点低于C组(P0.05T1T4时点两组间比较差别无统计学意义(P0.05)。两组T2T3T4S100β蛋白浓度均高于T1P0.01(见表2)

2.3两组细胞因子TNF-a水平的比较  UTNF-a浓度T2时点明显低于C P0.01),T3时点低于C组(P0.05T1T4时点两组间比较差别无统计学意义(P0.05)。CT2T3TNF-a水平明显高于T1p0.01),U组各时点TNF-a浓度比较差别均无统计学意义(P0.05(见表3)

参考文献

1      Nussmeier NA. Adverse neurologic eventsrisk 0f intracardiac Versus extracardiac surgery[J]. J Cardiothorac Vasc Anesth, 1996, 10:31-37.

2  谢立刚,胡小琴,吴新民,等.心血管手术后早期神经精神并发症的调查.中国循环杂志[J]200116(5) :369-371.

3  Nakamura H, Abe S, Shibata Y, et al. Inhibitor of neurophil elastase-induced interleukin-8 gene expression by urinary trypsin inhibitor in human bronchial epithelial cells[J]. Int Arch Allergy Immunol 1997,112(2):157-62.

4        Tanabe A, Sumita S, Ichimiya T, et al. Effect of ulinastation on extravascular lung water volume inpatients undergoing cardiopulmonary bypass[J]. Masui, 1994, 43(1): 78-88.

5        Blomquist S, Johnsson P, Luhrs C, et al. The appearance of S-100 protein in serum during and imediately afer cardiopulmonary bypass surgery: a possible marker for cerebral injury[J]. J Cardiothorac Vasc Anesth, 1997, 11:699-703.

6        Rosen H, Sunnerhagen KS, Herlitz J, et al. Serum levels of brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest[J]. Resuscitation, 2001,49:183-191.

7        Shaaban AM, Hamer M, Vauughan R. Serum S100 protein as a maker of cerebral damage during cardiac surgery[J]. Br J Anaesth, 2000,85:287-298.

8        Rocott HP, Croghwell ND, Verkerk GC, et al. Serum 100 as a predictor of neurologic and neuropsychologic outcome after cardiac surgery[J]. Anesth Analg, 1998,86:S65.

9        Lindberg L, Olsson AK, Anderson K, et al. Serum S100 protein levels after pediatric cardiac operations: a possible new maker for postoperative cerebral injury[J]. J Thorac Cardiovasc Surg, 1998,116:281-285.

10    Ali MS, Harmer M, Vaughan R. Serum S-100 protein as a marker of cerebral damage during cardiac surgery[J].Br J Anaesth ,2000,85(2):287-298.

11    Michetti F, Gazzolo D. S100B protein in biological fluids: a tool for perinatal medicine[J].Clin Chem,2002.48(12):2097-2104.

12    王咏. 体外循环与脑损伤. 中国胸心血管外科临床杂志[J] , 2003.10(2):128-130.

13    Wolman RL, Nussmeier NA, Aggarwal A, et al.Cerebral injury after cardiac surgery, identification of a group at extraordinary risk[J]. Stroke, 1999,30:514-522.

14    Murkin JM. Etiology and incidence of brain dysfunction after cardiac surgery[J]. J Cardiothorac Vasc Anesth, 1999, 13(4 Suppl 1): 12-17.

15    Taylor KM. Central nervous system effects of cardiopulmonary bypass[J]. Ann Thorac Surg, 1998,66 (5 Suppl): S20-24.

16    李李,沈金美,何小京,等. 乌司他丁对体外循环患者血浆细胞因子水平和呼吸指数的影响[J]. 中华麻醉学杂志, 2004, 248:578-581.

17    孟冬梅, 于金贵,周广利,等. 体外循环心脏直视手术期间乌司他丁对心肌缺血/再灌注损伤的保护作用[J]. 中华麻醉学杂志, 2002,226:344-347.

 

来顶一下
返回首页
返回首页

本周热点文章

站内搜索: 高级搜索
关于我们 | 主编信箱 | 广告查询 | 联系我们 | 网站地图 |